IC, Director CCL, PERT & Structural Heart, Chair NCVH Tampa Bay, #WashU #CLIFighters #ALILovers #ProScience - COI- I consult for everyone/Equally conflicted

Florida, USA
Jay Mathews MD, MS, FACC, FSCAI retweeted
New data. Live at #VIVA2026. 12-month results from the SELUTION4SFA FDA Study will be presented as late-breaking clinical data. 📅 Oct. 5 | 8:10 AM PT Presented by Principal Investigator @JayMathewsMD Explore the trial design ahead of the presentation: tinyurl.com/eycv9568 #CordisGoBeyond #SFA
1
268
Jay Mathews MD, MS, FACC, FSCAI retweeted
Big ideas. Live cases. Meaningful conversations. NYEVS 2026 is more than a conference — it’s where the vascular community comes together to learn, collaborate, and drive progress forward. See you there - register now! nyevs.org #InterventionalCardiology #Endovascular #CardioX @JayMathewsMD
2
6
831
The best way to submit science is over capuccino in ancient Roman palaces. See you at VEINS/VIVA 2026 at the Bellagio Vegas! @VIVAPhysicians #Split #DiocletianPalace #Croatia
1
11
846
Jay Mathews MD, MS, FACC, FSCAI retweeted
Live at NCVH 2026 — hands-on with the latest in peripheral intervention. We’re showcasing the new **Crosslead Tracker and Penetration wires** (excellent tracking in tortuosity, controlled cap engagement, and strong device support). Highlight of the week: Our official Asahi Intecc Lunch Symposium “It’s Time! Transforming PAD and CLTI Care from Top to Toe” 📍 Wednesday, May 27 • 12:00 – 1:00 PM 📍 Waldorf Ballroom Host: Dr. Craig Walker Keynote Speaker: Mr. Masahiko Miyata (Chairman & Founder, Asahi Intecc) Speakers: Dr. Ashwani Sastry, Dr. Jay Mathews, Dr. Osama Ibrahim Fellows, attendings, and lab teams — what PAD/CLTI topics do you hope they cover? Drop your thoughts or questions below 👇 #NCVH2026 #Crosslead #AsahiMedEd #PeripheralIntervention #CLTI #PAD #MedEd
2
3
1,157
Jay Mathews MD, MS, FACC, FSCAI retweeted
Celebrating an extraordinary career—congratulations to Kenneth Rosenfield, MD, MHCDS, MSCAI, recipient of the Helping Hearts Lifetime Service Award at #SCAI2026 🎉👏 A past SCAI President, his leadership, innovation, and lasting contributions have helped shape vascular and interventional medicine and improve patient care worldwide. @SrihariNaiduMD @sahilparikhmd
1
10
27
1,187
Delicious food and amazing PV faculty happening now at our dinner program in room 510a @SCAI Scientific Sessions 2026 in Montreal.
1
11
829
60 y/o with unknown thrombophilia on AC since 1990's. He was admitted to our sister hosp 3 weeks ago with syncope, extreme pain, and severe bilateral swelling. He went off DOACs 2 months prior due to cost. Had also prior Optease in 2017 for unclear indication. An adventure begins
2
1
11
1,823
Patient reports resolution of pain and LE swelling. Patient refusing enoxaparin so back on DOAC. Expensive and time consuming case but good outcome. Multimodality approach is sometimes key with mixed morphology clot. @NCVHonline @VIVAPhysicians @ISETNews @_backtable @WLGore
2
3
419